Patients use device to monitor AMD at home

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.
The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.
Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

Data could help guide treatment

July 16, 2021

Age-Related Macular Degeneration Artificial Intelligence Imaging

Clinical Research

NEI

DECA - Clinical Trials Branch DECA - Epidemiology Branch

Tiarnan Keenan

Tiarnan Keenan, NEI Division of Epidemiology and Clinical Applications, and colleagues found that people with age-related macular degeneration (AMD) can successfully use the Notal Home OCT device to monitor their disease. The device is part of a system developed by Notal Vision that uses artificial intelligence to measure fluid in the retina. Data from the system will help inform treatment decisions.